Search

Your search keyword '"Ulcerative colitis (UC)"' showing total 888 results

Search Constraints

Start Over You searched for: Descriptor "Ulcerative colitis (UC)" Remove constraint Descriptor: "Ulcerative colitis (UC)"
888 results on '"Ulcerative colitis (UC)"'

Search Results

1. Drug Interaction-Informed Approaches to Inflammatory Bowel Disease Management.

2. A Review of Fecal Microbiota Transplantation in Children—Exploring Its Role in the Treatment of Inflammatory Bowel Diseases.

3. Ulcerative colitis: molecular insights and intervention therapy.

4. Eosinophils and risk of ulcerative colitis in European population: Evidence from Mendelian randomization study.

5. Dipeptidyl peptidase 4: A predictor of ferroptosis in ulcerative colitis.

6. Ulcerative colitis: molecular insights and intervention therapy

7. Identifying polyamine related biomarkers in diagnosis and treatment of ulcerative colitis by integrating bulk and single-cell sequencing data

8. Placental Histopathological Lesions and Adverse Neonatal Outcomes in Patients with Inflammatory Bowel Diseases- A retrospective Cohort Study.

9. The learning curve for using intestinal ultrasonography.

10. Identifying polyamine related biomarkers in diagnosis and treatment of ulcerative colitis by integrating bulk and single-cell sequencing data.

11. Prospective therapeutic targets and recent advancements in the treatment of inflammatory bowel disease.

12. Functional evaluation of pure natural edible Ferment: protective function on ulcerative colitis.

13. Constructing a screening model to obtain the functional herbs for the treatment of active ulcerative colitis based on herb-compound-target network and immuno-infiltration analysis.

14. Gastrointestinal Diseases

17. Blockade of PI3K/AKT signaling pathway by Astragaloside IV attenuates ulcerative colitis via improving the intestinal epithelial barrier

18. How the Western Diet Thwarts the Epigenetic Efforts of Gut Microbes in Ulcerative Colitis and Its Association with Colorectal Cancer.

19. Exploring Electrical Neuromodulation as an Alternative Therapeutic Approach in Inflammatory Bowel Diseases.

20. Echinacea purpurea Polysaccharide Ameliorates Dextran Sulfate Sodium-Induced Colitis by Restoring the Intestinal Microbiota and Inhibiting the TLR4-NF-κB Axis.

21. Blockade of PI3K/AKT signaling pathway by Astragaloside IV attenuates ulcerative colitis via improving the intestinal epithelial barrier.

22. Inferencing Medical Knowledge from an Artificial Neural Network in Inflammatory Bowel Disease.

23. Extrachromosomal Circular DNA: An Emerging Potential Biomarker for Inflammatory Bowel Diseases?

24. Oxidative Stress-Responsive Apoptosis Inducing Protein (ORAIP) Plays a Critical Role in Dextran Sulfate Sodium-Induced Murine Model of Ulcerative Colitis.

25. Non-alcoholic fatty liver disease (NAFLD) and obesity in inflammatory bowel disease (IBD) patients in Gorgan.

26. Moxifloxacin promotes two-photon microscopic imaging for discriminating different stages of DSS-induced colitis on mice

27. Serum CXCL 9 as a Potential Biomarker for Patients with Ulcerative Colitis

28. Non-alcoholic fatty liver disease (NAFLD) and obesity in inflammatory bowel disease (IBD) patients in Gorgan

29. A Review of Fecal Microbiota Transplantation in Children—Exploring Its Role in the Treatment of Inflammatory Bowel Diseases

30. Drug Interaction-Informed Approaches to Inflammatory Bowel Disease Management

31. Elucidating the role of TWIST1 in ulcerative colitis: a comprehensive bioinformatics and machine learning approach.

32. Increasing Adoption of Laparoscopy in Urgent and Emergent Colectomies for Pediatric Ulcerative Colitis.

33. Osteopathische Behandlungsmöglichkeiten chronisch entzündlicher Darmerkrankungen: Eine qualitative Analyse von Interviews.

34. Baricitinib relieves DSS-induced ulcerative colitis in mice by suppressing the NF-κB and JAK2/STAT3 signalling pathways.

35. Short Chain Fatty Acids: Essential Weapons of Traditional Medicine in Treating Inflammatory Bowel Disease.

36. Evolving Landscape of Paediatric Inflammatory Bowel Disease: Insights from a Decade-Long Study in North-East Slovenia on Incidence, Management, Diagnostic Delays, and Early Biologic Intervention.

37. Changes in intestinal microbiota and biochemical parameters in patients with inflammatory bowel disease and irritable bowel syndrome induced by the prolonged addition of soluble fibers to usual drug therapy.

38. Short-term efficacy of vedolizumab in patients with inflammatory bowel disease in real-life settings in Bosnia and Herzegovina

39. Quality of reporting of integrative Chinese and Western medicine intervention in randomized controlled trials of ulcerative colitis: a review

42. Pouchitis and Pouch-Related Complications

44. The Management of Inflammatory Bowel Disease during Reproductive Years: An Updated Narrative Review

45. Momordica charantia Polysaccharide intervention ameliorates the symptoms of dextran sulfate sodium (DSS)-induced colitis by modulating gut microbiota and inhibiting inflammation

46. Quality of reporting of integrative Chinese and Western medicine intervention in randomized controlled trials of ulcerative colitis: a review.

47. Inflammatory Bowel Disease: Pathophysiology, Treatment, and Disease Modeling.

48. Agaricus blazei Polysaccharide Alleviates DSS-Induced Colitis in Mice by Modulating Intestinal Barrier and Remodeling Metabolism.

49. Unsuitability of the Oxidation-Reduction Potential Measurement for the Quantification of Fecal Redox Status in Inflammatory Bowel Disease.

50. Association between systemic lupus erythematosus and inflammatory bowel disease in European and East Asian populations: a two-sample Mendelian randomization study.

Catalog

Books, media, physical & digital resources